Integrated proteogenomic analysis for inherited bone marrow failure syndrome.
Journal
Leukemia
ISSN: 1476-5551
Titre abrégé: Leukemia
Pays: England
ID NLM: 8704895
Informations de publication
Date de publication:
13 May 2024
13 May 2024
Historique:
received:
17
02
2024
accepted:
23
04
2024
revised:
19
04
2024
medline:
14
5
2024
pubmed:
14
5
2024
entrez:
13
5
2024
Statut:
aheadofprint
Résumé
Recent advances in in-depth data-independent acquisition proteomic analysis have enabled comprehensive quantitative analysis of >10,000 proteins. Herein, an integrated proteogenomic analysis for inherited bone marrow failure syndrome (IBMFS) was performed to reveal their biological features and to develop a proteomic-based diagnostic assay in the discovery cohort; dyskeratosis congenita (n = 12), Fanconi anemia (n = 11), Diamond-Blackfan anemia (DBA, n = 9), Shwachman-Diamond syndrome (SDS, n = 6), ADH5/ALDH2 deficiency (n = 4), and other IBMFS (n = 18). Unsupervised proteomic clustering identified eight independent clusters (C1-C8), with the ribosomal pathway specifically downregulated in C1 and C2, enriched for DBA and SDS, respectively. Six patients with SDS had significantly decreased SBDS protein expression, with two of these not diagnosed by DNA sequencing alone. Four patients with ADH5/ALDH2 deficiency showed significantly reduced ADH5 protein expression. To perform a large-scale rapid IBMFS screening, targeted proteomic analysis was performed on 417 samples from patients with IBMFS-related hematological disorders (n = 390) and healthy controls (n = 27). SBDS and ADH5 protein expressions were significantly reduced in SDS and ADH5/ALDH2 deficiency, respectively. The clinical application of this first integrated proteogenomic analysis would be useful for the diagnosis and screening of IBMFS, where appropriate clinical screening tests are lacking.
Identifiants
pubmed: 38740980
doi: 10.1038/s41375-024-02263-1
pii: 10.1038/s41375-024-02263-1
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Japan Agency for Medical Research and Development (AMED)
ID : 22K15601
Informations de copyright
© 2024. The Author(s).
Références
Gilad O, Dgany O, Noy-Lotan S, Krasnov T, Yacobovich J, Rabinowicz R, et al. Syndromes predisposing to leukemia are a major cause of inherited cytopenias in children. Haematologica. 2022;107:2081–95.
doi: 10.3324/haematol.2021.280116
pubmed: 35295078
pmcid: 9425329
Wegman-Ostrosky T, Savage SA. The genomics of inherited bone marrow failure: from mechanism to the clinic. Br J Haematol. 2017;177:526–42.
doi: 10.1111/bjh.14535
pubmed: 28211564
Park M. Overview of inherited bone marrow failure syndromes. Blood Res. 2022;57:49–54.
doi: 10.5045/br.2022.2022012
pubmed: 35483926
pmcid: 9057667
Oka Y, Hamada M, Nakazawa Y, Muramatsu H, Okuno Y, Higasa K, et al. Digenic mutations in ALDH2 and ADH5 impair formaldehyde clearance and cause a multisystem disorder, AMeD syndrome. Sci Adv. 2020;6:eabd7197.
doi: 10.1126/sciadv.abd7197
pubmed: 33355142
Dingler FA, Wang M, Mu A, Millington CL, Oberbeck N, Watcham S, et al. Two Aldehyde Clearance Systems Are Essential to Prevent Lethal Formaldehyde Accumulation in Mice and Humans. Mol Cell. 2020;80:996–1012.e1019.
doi: 10.1016/j.molcel.2020.10.012
pubmed: 33147438
pmcid: 7758861
Alter BP. Inherited bone marrow failure syndromes: considerations pre- and posttransplant. Blood. 2017;130:2257–64.
doi: 10.1182/blood-2017-05-781799
pubmed: 29167174
pmcid: 5714231
Muramatsu H, Okuno Y, Yoshida K, Shiraishi Y, Doisaki S, Narita A, et al. Clinical utility of next-generation sequencing for inherited bone marrow failure syndromes. Genet Med. 2017;19:796–802.
doi: 10.1038/gim.2016.197
pubmed: 28102861
Zhang MY, Keel SB, Walsh T, Lee MK, Gulsuner S, Watts AC, et al. Genomic analysis of bone marrow failure and myelodysplastic syndromes reveals phenotypic and diagnostic complexity. Haematologica. 2015;100:42–48.
doi: 10.3324/haematol.2014.113456
pubmed: 25239263
pmcid: 4281311
Ghemlas I, Li H, Zlateska B, Klaassen R, Fernandez CV, Yanofsky RA, et al. Improving diagnostic precision, care and syndrome definitions using comprehensive next-generation sequencing for the inherited bone marrow failure syndromes. J Med Genet. 2015;52:575–84.
doi: 10.1136/jmedgenet-2015-103270
pubmed: 26136524
Shimamura A, Alter BP. Pathophysiology and management of inherited bone marrow failure syndromes. Blood Rev. 2010;24:101–22.
doi: 10.1016/j.blre.2010.03.002
pubmed: 20417588
pmcid: 3733544
Boocock GR, Morrison JA, Popovic M, Richards N, Ellis L, Durie PR, et al. Mutations in SBDS are associated with Shwachman-Diamond syndrome. Nat Genet. 2003;33:97–101.
doi: 10.1038/ng1062
pubmed: 12496757
Zhou HB, Li Q, Liu M, Cao YQ, Xu JY. Increased expression of long non-coding RNA SBDSP1 correlates with poor survival in colorectal cancer. Eur Rev Med Pharm Sci. 2017;21:3837–41.
Reilly CR, Shimamura A. Predisposition to myeloid malignancies in Shwachman-Diamond syndrome: Biological insights and clinical advances. Blood. 2023;141:1513–23.
Chen S, Francioli LC, Goodrich JK, Collins RL, Kanai M, Wang Q, et al. A genome-wide mutational constraint map quantified from variation in 76,156 human genomes. bioRxiv. 2022. https://www.biorxiv.org/content/10.1101/2022.03.20.485034v1 .
Kawashima Y, Nagai H, Konno R, Ishikawa M, Nakajima D, Sato H, et al. Single-Shot 10K Proteome Approach: Over 10,000 Protein Identifications by Data-Independent Acquisition-Based Single-Shot Proteomics with Ion Mobility Spectrometry. J Proteome Res. 2022;21:1418–27.
doi: 10.1021/acs.jproteome.2c00023
pubmed: 35522919
pmcid: 9171847
Kawashima Y, Watanabe E, Umeyama T, Nakajima D, Hattori M, Honda K, et al. Optimization of Data-Independent Acquisition Mass Spectrometry for Deep and Highly Sensitive Proteomic Analysis. Int J Mol Sci. 2019;20:5932.
doi: 10.3390/ijms20235932
pubmed: 31779068
pmcid: 6928715
Petralia F, Tignor N, Reva B, Koptyra M, Chowdhury S, Rykunov D, et al. Integrated Proteogenomic Characterization across Major Histological Types of Pediatric Brain. Cancer Cell. 2020;183:1962–85 e1931.
Clark DJ, Dhanasekaran SM, Petralia F, Pan J, Song X, Hu Y, et al. Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma. Cell. 2019;179:964–83.e931.
doi: 10.1016/j.cell.2019.10.007
pubmed: 31675502
pmcid: 7331093
Furutani E, Liu S, Galvin A, Steltz S, Malsch MM, Loveless SK, et al. Hematologic complications with age in Shwachman-Diamond syndrome. Blood Adv. 2022;6:297–306.
doi: 10.1182/bloodadvances.2021005539
pubmed: 34758064
pmcid: 8753194
Kawashima Y, Miyata J, Watanabe T, Shioya J, Arita M, Ohara O. Proteogenomic Analyses of Cellular Lysates Using a Phenol-Guanidinium Thiocyanate Reagent. J Proteome Res. 2019;18:301–8.
pubmed: 30394753
Amodei D, Egertson J, MacLean BX, Johnson R, Merrihew GE, Keller A, et al. Improving Precursor Selectivity in Data-Independent Acquisition Using Overlapping Windows. J Am Soc Mass Spectrom. 2019;30:669–84.
doi: 10.1007/s13361-018-2122-8
pubmed: 30671891
pmcid: 6445824
MacLean B, Tomazela DM, Shulman N, Chambers M, Finney GL, Frewen B, et al. Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics. 2010;26:966–8.
doi: 10.1093/bioinformatics/btq054
pubmed: 20147306
pmcid: 2844992
Grossegesse M, Hartkopf F, Nitsche A, Doellinger J. Stable Isotope-Triggered Offset Fragmentation Allows Massively Multiplexed Target Profiling on Quadrupole-Orbitrap Mass Spectrometers. J Proteome Res. 2020;19:2854–62.
doi: 10.1021/acs.jproteome.0c00065
pubmed: 32369372
Sato H, Nakajima D, Ishikawa M, Konno R, Nakamura R, Ohara O, et al. Evaluation of the Suitability of Dried Saliva Spots for In-Depth Proteome Analyses for Clinical Applications. J Proteome Res. 2022;21:1340–8.
doi: 10.1021/acs.jproteome.2c00099
pubmed: 35446574
Thul PJ, Lindskog C. The human protein atlas: A spatial map of the human proteome. Protein Sci. 2018;27:233–44.
doi: 10.1002/pro.3307
pubmed: 28940711
Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.
doi: 10.1186/s13059-014-0550-8
pubmed: 25516281
pmcid: 4302049
Hanzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinforma. 2013;14:7.
doi: 10.1186/1471-2105-14-7
Newman AM, Steen CB, Liu CL, Gentles AJ, Chaudhuri AA, Scherer F, et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat Biotechnol. 2019;37:773–82.
doi: 10.1038/s41587-019-0114-2
pubmed: 31061481
pmcid: 6610714
Bhoopalan SV, Yen JS, Mayuranathan T, Mayberry KD, Yao Y, Lillo Osuna MA, et al. An RPS19-edited model for Diamond-Blackfan anemia reveals TP53-dependent impairment of hematopoietic stem cell activity. JCI insight. 2023;8:e161810.
doi: 10.1172/jci.insight.161810
pubmed: 36413407
pmcid: 9870085
Yamada M, Uehara T, Suzuki H, Takenouchi T, Inui A, Ikemiyagi M, et al. Shortfall of exome analysis for diagnosis of Shwachman-Diamond syndrome: Mismapping due to the pseudogene SBDSP1. Am J Med Genet Part A. 2020;182:1631–6.
doi: 10.1002/ajmg.a.61598
pubmed: 32412173
Myers KC, Furutani E, Weller E, Siegele B, Galvin A, Arsenault V, et al. Clinical features and outcomes of patients with Shwachman-Diamond syndrome and myelodysplastic syndrome or acute myeloid leukaemia: a multicentre, retrospective, cohort study. Lancet Haematol. 2020;7:e238–e246.
doi: 10.1016/S2352-3026(19)30206-6
pubmed: 31879230
Cazzola M. Myelodysplastic Syndromes. N. Engl J Med. 2020;383:1358–74.
doi: 10.1056/NEJMra1904794
pubmed: 32997910
Lindsley RC, Saber W, Mar BG, Redd R, Wang T, Haagenson MD, et al. Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation. N. Engl J Med. 2017;376:536–47.
doi: 10.1056/NEJMoa1611604
pubmed: 28177873
pmcid: 5438571
Myers K, Hebert K, Antin J, Boulad F, Burroughs L, Hofmann I, et al. Hematopoietic Stem Cell Transplantation for Shwachman-Diamond Syndrome. Biol Blood Marrow Transplant. 2020;26:1446–51.
doi: 10.1016/j.bbmt.2020.04.029
pubmed: 32428734
pmcid: 7371524
Donadieu J, Fenneteau O, Beaupain B, Beaufils S, Bellanger F, Mahlaoui N, et al. Classification of and risk factors for hematologic complications in a French national cohort of 102 patients with Shwachman-Diamond syndrome. Haematologica. 2012;97:1312–9.
doi: 10.3324/haematol.2011.057489
pubmed: 22491737
pmcid: 3436231